Average Co-Inventor Count = 3.18
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (12 from 666 patents)
2. Bristol-myers Squibb Pharma Company (6 from 234 patents)
3. Incyte Holdings Corporation (5 from 147 patents)
4. Dupont Pharmaceuticals Company (5 from 106 patents)
5. Bristol-myers Squibb Compnay (3 from 3,685 patents)
6. Other (2 from 832,880 patents)
7. The Dupont Merck Pharmaceutical Company (2 from 206 patents)
8. Enanta Pharmaceuticals, Inc. (1 from 292 patents)
9. Asana Biosciences, LLC (1 from 34 patents)
10. Verastem, Inc. (1 from 13 patents)
11. Actimis Pharmaceuticals, Inc. (1 from 8 patents)
12. Endo Pharmaceuticals Inc. (32 patents)
13. Endo Pharmaceuticals Solutions Inc. (26 patents)
34 patents:
1. 11414427 - Solid forms of stemospironine and its salts
2. 11213528 - Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
3. 10610530 - Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
4. 10125150 - Crystalline forms of a PI3K inhibitor
5. 10016429 - Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
6. 9988401 - Crystalline forms of a PI3K inhibitor
7. 9505719 - Synthesis and use of kinase inhibitors
8. 9464088 - Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
9. 9376439 - Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
10. 9126991 - Radezolid salts and polymorphic forms thereof
11. 8865741 - Aminoindane compounds and use thereof in treating pain
12. 8829013 - Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
13. 8822481 - Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
14. 8765734 - Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
15. 8722693 - Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile